Artesunate Amivas 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification1 
Decision 
Information 
issued on 
Issued2 / 
affected3  
amended 
on 
N/0010 
Minor change in labelling or package leaflet not 
08/11/2023 
Labelling 
connected with the SPC (Art. 61.3 Notification) 
PSUSA/10958
Periodic Safety Update EU Single assessment - 
20/07/2023 
05/10/2023 
SmPC and PL 
Refer to Scientific conclusions and grounds recommending 
/202212 
artesunate 
the variation to terms of the Marketing Authorisation(s)’ for 
1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European Union 
 
 
 
 
 
 
  
 
 
 
 
 
 
PSUSA/10958/202212. 
IAIN/0009 
A.5.a - Administrative change - Change in the name 
04/10/2023 
Annex II and 
and/or address of a manufacturer/importer 
responsible for batch release 
IAIN/0007 
A.1 - Administrative change - Change in the name 
16/08/2023 
and/or address of the MAH 
PL 
SmPC, 
Labelling and 
PL 
II/0004 
C.I.4 - Change(s) in the SPC, Labelling or PL due to 
06/07/2023 
05/10/2023 
SmPC 
new quality, preclinical, clinical or pharmacovigilance 
data 
IB/0005 
C.z - Safety, Efficacy, Pharmacovigilance changes - 
03/07/2023 
n/a 
Other variation 
IB/0006 
B.I.b.z - Change in control of the AS - Other 
16/06/2023 
n/a 
variation 
IB/0002 
C.I.z - Changes (Safety/Efficacy) of Human and 
06/03/2023 
04/04/2023 
Veterinary Medicinal Products - Other variation 
PSUSA/10958
Periodic Safety Update EU Single assessment - 
12/01/2023 
n/a 
PRAC Recommendation - maintenance 
/202206 
artesunate 
Page 2/2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
